FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder - Managed Healthcare Executive

Submitted by Anonymous (not verified) on Wed, 01/22/2025 - 05:38

FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder  Managed Healthcare Executive